Skip to main content
Sanofi
Healthcare · Drug Manufacturers - General
Made on Jul 25, 2026
Price at call $43.36
6-month call Bull +10.2%
Target by Jan 2027 $47.80
Great value below $39.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +10.2% to $47.80
Predicted High $47.80 at 6 months
Predicted Low $42.60 at 1 month
Max Drawdown (predicted) -1.8%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Jul 25, 2026 12:11 pm
Bull SNY trends higher to $47.80 (+10.2% from $43.36) by Jan 2027. dip-then-recover
ThesisSNY trades at a discount to composite fair value but a fresh pipeline failure and negative sentiment cap near-term upside. Low beta and earnings-beat history support a slow drift higher toward mid-40s, with value gravity pulling toward high-40s only if sentiment stabilizes.
Invalidated ifBreak below $40.64 bear scenario on further pipeline setbacks, or failure to reclaim $45 within 2 months
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $43.36 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Jul 25, 2026 $43.36 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 8, 2026 $41.00–$45.72 typical range · internal point $42.90 ±5.4% 6/10 pipeline failure overhang keeps pressure near term
What actually happened: closed $43.50 on Aug 7, 2026 = +0.3% vs the call (predicted -1.1%)  ·  direction HIT (called flat, was flat)  ·  off by 1.4 pp  ·  accuracy 10/10  ·  typical range ±5.4%: inside the band  ·  S&P +4.7% over the same window — beat it
1 month Aug 25, 2026 $39.94–$46.78 typical range · internal point $42.60 ±7.9% 5/10 sentiment drift continues absent catalyst
2 months Sep 25, 2026 $43.50 +0.3% 5/10 stabilization as narrative digested
3 months Oct 25, 2026 $44.80 +3.3% 5/10 earnings beat pattern reasserts, value gravity begins
4 months Nov 25, 2026 $46.20 +6.5% 4/10 discount to fair value attracts defensive buyers
5 months Dec 25, 2026 $47.00 +8.4% 4/10 low-beta compounding toward composite anchor
6 months Jan 25, 2027 $47.80 +10.2% 4/10 partial convergence toward $55 fair value

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $48.60 (+12.1%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 1 degraded · 1 note — follow the chain top-down (cause → effect).
  • Degraded
    Sector in contraction — demand weakening across the industry
    upstream:valuation-synthesis
  • Note
    Valuation anchor absent: dcf.
    anchor:dcf

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$43.36
Composite fair value$55.05
Signal-adjusted fair value$54.60
DCF fair value
Anchored-PE fair value$74.53
Buy-below (value lens)$39.00
Value net score+18
Value confidence6 / 10
Quality net score+33
Memo confidence6 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 25.3%  3m 27.3%  6m 25.4%  
Daily σ (realism noise)1.7%
Beta vs S&P 500 1m -0.14  3m 0.30  5m 0.38  
Trailing 6-month return-6.8%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 8, 2026 16d behind SNY-20260708-030001-27e5
ext-forensic-memo Jul 24, 2026 freshest ext-SNY-20260724-091352-a789
ext-lens-quality Jul 24, 2026 freshest ext-SNY-20260724-091352-a789
ext-lens-sentiment Jul 24, 2026 freshest ext-SNY-20260724-091352-a789
ext-lens-value Jul 24, 2026 freshest ext-SNY-20260724-091352-a789
scenario-valuation Jul 24, 2026 freshest SNY-20260723-124200-4c25
valuation-synthesis Jul 24, 2026 freshest SNY-20260724-090704-c9a2

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

4 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 1, 2026 v0.6.0 Bull $43.08 $51.25 +19.0% Feb 2027 view
Jul 25, 2026 v0.6.0 Bull $43.36 $47.80 +10.2% Jan 2027 viewing
Jul 24, 2026 v0.6.0 Bear $43.36 $38.50 -11.2% Jan 2027 view
Jul 8, 2026 v0.3.0 Bull $42.98 $60.11 +39.9% Jan 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.